The clickable links below navigate directly to outside media articles which featured Department of Medicine faculty and staff throughout the month of September 2025.
Millie Long, MD, MPH, and Edward Barnes, MD, MPH, played key roles in developing the first international guidelines for managing inflammatory bowel disease during pregnancy.
Christine Vigeland, MD, received at R03 from the NIH National Heart Lung and Blood Institute to study the role of lipid metabolism in lung macrophage activity.
The Center for Gastrointestinal Biology and Disease received its 40th consecutive year of NIH funding.
David Wohl, MD, clarified whose still eligible for the COVID vaccine in NC.
Drs. David Wohl and David Weber teamed up to provide updates on the new COVID variant.
Jonathan Parr, MD, MPH, provided updates on drug resistant strains of malaria.
Sidney C. Smith, Jr., MD, updated guidelines for taking patients’ blood pressure.
David J. Weber, MD, MPH, participated in a video interview with Infection Control Today regarding the CDC.
Klara Klein, MD, PhD, announced the first patient has been enrolled in a trial on Cadisegliatin for type 1 diabetes.
John Buse, MD, PhD, gave insights to what Type 1.5 diabetes is.
Christopher Sellers, MD, discussed the infectious diseases fellowship program, its diverse professional opportunities and provided some insights as to why many ID trainees stay at UNC.
Nigel Key, MB, ChB, FRCP, outlined the financial barriers to gene therapy for patients.
Prabir Roy-Chaudhury, MD, PhD, spoke about AMA’s request for physician exemption from a new $100,000 fee on H-1B visa applications.
John Buse, MD, co-published ‘Step Up T2D” on the efficacy of higher semaglutide doses.
Evan Dellon, MD, MPH, led a Phase 3 Trial on using Cendakimab for Eosinophilic Esophagitis.
Safe care starts here. Learn how we put patient safety into practice from projects led by Kenton Dover, MD, Honey Jones, DNP, Angela Perhac, PharmD, Terre Oosterwyk, RN, Claire Farel, MD, John Pryor, Anand Shah, MD, MBA, Scott Keller, Joseph Rossi, MD, and Cody Deen, MD.
The NIH/NIDDK funded NC Diabetes Research Center, a consortium of UNC, WakeForest, Duke and NCA&T to support diabetes research across institutions, has been renewed.